ABSTRACT SUBMISSION
The 13th International RSV Symposium
Hotel Bourbon, Iguazu Falls, Brazil
Deadline 23.59, US Pacific time, Friday 18th October 2024
Guidelines
Submission Category: Abstracts may be submitted under one of the following categories:
RSV Immunopathogenesis
RSV Molecular Virology
RSV Immunology and Biomarkers
RSV Clinical Aspects in Vulnerable Populations
RSV Vaccines - from development to clinical studies
Real World Vaccine Effectiveness and Health Economics
RSV Monoclonal Antibodies and Antivirals
RSV Transmission & Control Strategies
Beyond RSV: Pneumoviridae and bacteria
Development of Global Surveillance and Country Experience of RSV Vaccine Implementation
Publication: Upon submission of an abstract, the author provides consent to ISIRV to publish the abstract on its platforms, as appropriate.
Co-Author Approval: Ensure that all co-authors approve of the abstract submission, publication, and potential presentation. Abstracts cannot be changed or withdrawn after the 18th October 2024.
Author Disclosure: All abstract authors are required to disclose any conflict of interest.
Changes to Abstract: You are able to edit your abstract until the submission deadline. The deadline for minor updates and all withdrawals is the 18th October 2024. Any corrections and/or changes will not be accepted after these dates. For further guidance, contact isirv RSV Conference secretariat.
Abstract Receipt Confirmation: You should receive email confirmation within two hours of submitting your abstract. If, after checking your spam folder, you have not received this confirmation then please contact Quad Logic technical support.
Consent: We collect personal data related to abstract submitters, presenters and authors together with scientific abstract data. This is to enable the usage of the ISIRV Abstract submission module. We ensure your personal data is processed lawfully, fairly and transparently and in accordance with Article 6 of the EU GDPR. When submitting abstracts though our service you confirm that you the submitter / presenting author, has the consent of the authors and scientific team involved to disclose their personal information and scientific abstract.
Access to Data: Submitters and authors have the right to i) request access to, deletion of or correction of, personal data held by us at no cost to you; ii) be informed of what data processing is taking place; iii) restrict processing; iv) to object to processing of personal data; and v) complain to a supervisory authority.
Questions:
Abstract / privacy policy, deadlines, notifications, programming, general conference questions, contact isirv RSV Conference secretariat.
Technical support questions related to problems with online abstract submission, contact Quad Logic.
Layout
Abstract Preparation: Abstracts must conform exactly to the instructions provided for electronic submission. Abstracts must be submitted in English and all presentations will be in English.
Layout of Submission: Each abstract will need to include the title, background, methods, results and conclusion.
Character Limit: A complete abstract submission will be a maximum of 2,750 characters. This includes the background, methods, tables, figures, results, conclusions and spaces. This does NOT include the title, authors and institutions.
File Attachment: File attachment is only for additional figures or tables with the content character count taken into consideration. This facility is not used to upload abstracts by pdf.